Aspen Pharmacare Holdings Ltd logo

Aspen Pharmacare Holdings Ltd - ADR

OTCPK:APNHY (South Africa)   ADR
$ 11.29 0 (0%) 10:08 PM EST
19.23
P/B:
1.10
Volume:
-
Avg Vol (2M):
718.00
Also Trade In:
Volume:
-
Avg Vol (2M):
718.00
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Aspen Pharmacare Holdings Ltd ( ) from 2009 to Apr 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Aspen Pharmacare stock (APNHY) PE ratio as of Apr 27 2024 is 19.23. More Details

Aspen Pharmacare Holdings Ltd (APNHY) PE Ratio (TTM) Chart

To

Aspen Pharmacare Holdings Ltd (APNHY) PE Ratio (TTM) Historical Data

Total 1215
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Aspen Pharmacare PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-28 19.2 2024-02-23 17.1
2024-04-26 19.2 2024-02-22 17.1
2024-04-25 19.2 2024-02-21 17.1
2024-04-24 18.7 2024-02-20 18.1
2024-04-23 19.0 2024-02-16 18.1
2024-04-22 19.7 2024-02-15 17.5
2024-04-19 19.7 2024-02-14 17.5
2024-04-18 19.7 2024-02-13 17.1
2024-04-17 19.7 2024-02-12 17.1
2024-04-16 19.7 2024-02-09 17.9
2024-04-15 19.7 2024-02-08 17.9
2024-04-12 19.7 2024-02-07 17.9
2024-04-11 19.7 2024-02-06 17.9
2024-04-10 19.7 2024-02-05 17.9
2024-04-09 19.7 2024-02-02 17.9
2024-04-08 19.7 2024-02-01 17.9
2024-04-05 19.7 2024-01-31 17.9
2024-04-04 19.7 2024-01-30 17.9
2024-04-03 19.7 2024-01-29 17.9
2024-04-02 19.7 2024-01-26 17.9
2024-04-01 19.6 2024-01-25 17.1
2024-03-28 19.6 2024-01-24 17.1
2024-03-27 19.6 2024-01-23 17.8
2024-03-26 19.6 2024-01-22 17.8
2024-03-25 19.6 2024-01-19 17.8
2024-03-22 19.6 2024-01-18 17.8
2024-03-21 19.6 2024-01-17 17.8
2024-03-20 19.1 2024-01-16 18.5
2024-03-19 19.1 2024-01-12 18.5
2024-03-18 19.1 2024-01-11 18.7
2024-03-15 19.1 2024-01-10 18.7
2024-03-14 19.1 2024-01-09 18.7
2024-03-13 18.6 2024-01-08 18.7
2024-03-12 18.6 2024-01-05 18.7
2024-03-11 18.6 2024-01-04 18.7
2024-03-08 18.4 2024-01-03 18.7
2024-03-07 18.2 2024-01-02 18.7
2024-03-06 17.7 2023-12-29 18.7
2024-03-05 17.7 2023-12-28 18.8
2024-03-04 18.3 2023-12-27 16.8
2024-03-01 17.3 2023-12-26 16.8
2024-02-29 17.3 2023-12-22 16.8
2024-02-28 17.1 2023-12-21 15.9
2024-02-27 17.1 2023-12-20 15.9
2024-02-26 17.1 2023-12-19 15.9

Aspen Pharmacare Holdings Ltd (APNHY) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.